SSF Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV) 2024: Interactive Chart & Historical Data

Latest value: 89.46 (2024-01-01)

Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV) is an important economic indicator for SSF, providing insights into structural trends, policy impacts, and development trajectories. This metric is widely used by researchers, analysts, and policymakers to monitor economic conditions and inform decision-making. In SSF, Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV) reflects the interplay of domestic policies, global market forces, and long-term demographic and technological changes. Tracking this indicator over time reveals patterns of growth, volatility, and structural transformation that shape the country's economic outlook. Access to reliable, timely data is essential for evidence-based analysis, whether for academic research, investment strategy, or public policy evaluation. The most recent data point shows 89.46 as of 2024-01-01. This dataset spans 2000–2024, covering 25 annual observations. Data is sourced from World Bank and updated regularly on EconDash. Use EconDash's interactive chart to explore Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV) data, apply custom date ranges, and benchmark SSF against peer economies.